跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 113 条关于
“nHCM”
全部
113
临床试验
83
药物
4
机构
0
资讯
26
2个月前
Imbria's Ninerafaxstat Wins FDA Orphan Drug Designation for Non-Obstructive Hypertrophic Cardiomyopathy
11个月前
Imbria Pharmaceuticals Partners with Patient Advocacy Group to Accelerate Recruitment for Novel Heart Disease Trial
3个月前
HAYA Therapeutics Doses First Patients in Phase 1 Trial of HTX-001 for Cardiac Fibrosis
8个月前
Edgewise Therapeutics Reports Positive Phase 2 Data for Cardiac Sarcomere Modulator EDG-7500 in Hypertrophic Cardiomyopathy
10个月前
Imbria Pharmaceuticals Secures Extended Series B Funding to Advance First-in-Class Cardiovascular Therapy Ninerafaxstat
去年
Cytokinetics Initiates Phase 2 Trial of CK-586 for Heart Failure with Preserved Ejection Fraction
17天前
Braveheart Bio to Present at Cantor Global Healthcare Conference as It Advances BHB-1893 for Hypertrophic Cardiomyopathy
去年
Lexicon Pharmaceuticals Initiates Phase 3 Trial of Sotagliflozin for Hypertrophic Cardiomyopathy
去年
HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Medicines Targeting the "Dark Genome"
去年
Bristol Myers Squibb to Present New Cardiovascular Data at ESC Congress 2025, Including Breakthrough Non-Obstructive HCM Trial Results
第 1 页,共 3 页
上一页
下一页